Page last updated: 2024-11-06

oxodipine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID56108
CHEMBL ID2105319
SCHEMBL ID332244
MeSH IDM0152229

Synonyms (29)

Synonym
oxodipine
iqb-837v
oxodipine [inn]
oxodipino [spanish]
3,5-pyridinedicarboxylic acid, 1,4-dihydro-4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-, ethyl methyl ester
ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(2,3-(methylenedioxy)phenyl)-3,5-pyridinedicarboxylate
iqb-837-v
oxodipinum [latin]
5-o-ethyl 3-o-methyl 4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
90729-41-2
gpe63j28f0 ,
unii-gpe63j28f0
oxodipino
oxodipinum
oxodipine [who-dd]
CHEMBL2105319
SCHEMBL332244
oxodipine, (-)-
3,5-pyridinedicarboxylic acid, 4-(1,3-benzodioxol-4-yl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester, (+)-
7T54300UMS ,
119914-33-9
oxodipine, (+)-
2MTW8YSX8G ,
119914-34-0
3,5-pyridinedicarboxylic acid, 4-(1,3-benzodioxol-4-yl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester, (-)-
unii-7t54300ums
unii-2mtw8ysx8g
DTXSID50869063
Q7115729

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Pretreatment with oxodipine significantly reduced the infarct size in the apical and basal myocardium (P < 0.05)."( Effects of oxodipine and nitrendipine on the size of experimental myocardial infarct in the rat.
Gil-Loyzaga, P; Merchàn-Pérez, A; Pérez-Cao, A; Tamargo, J, 1994
)
1

Bioavailability

ExcerptReferenceRelevance
" Absolute bioavailability can be modulated by different formulations."( An original intragastric delivery system for oral administration of solid formulations to fully conscious rats: its application to oxodipine studies.
Dufour, A; Egros, F; Hulot, T; Lhot, O; Stypulkowski, M, 1991
)
0.49

Dosage Studied

ExcerptRelevanceReference
" It is postulated that subchronic administration of oxodipine at this dosage resulted in a decrease in blood pressure, with uninterrupted stimulation of the adrenal zona glomerulosa to release aldosterone, causing an increase in the width of this portion of the gland involving cellular hyperplasia."( Thickening of the adrenal zona glomerulosa in dogs induced by oxodipine, a calcium channel blocker.
Dayan, D; Galiano, A; Nyska, A; Shapira, S; Skutelski, E; Waner, T, 1992
)
0.77
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (20.69)18.7374
1990's21 (72.41)18.2507
2000's1 (3.45)29.6817
2010's1 (3.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.85 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.13%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]